COMBINING TARGETED RADIONUCLIDE THERAPY AND EPIGENETIC REGULATORS FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER.

University Of Wisconsin System, Madison WI

Investigators